In these lines, a series of studies in the context of tauopathy, aging, and AD suggests that co-regulatory signaling through PD-L1 and PD-1 may improve neuropathology and associated cognitive impairments, highlighting the relevance of this checkpoint in the CNS23,45–47. This evidence concerns the gene PDCD1 and tauopathy.